Related Experiment Video
Updated: Jun 28, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Antibody-Assisted Protection from Paraoxon and Nerve Agent Model Compounds
Charles M Thompson1, Jorge Gomez-Galeno1, John R Cashman1
1Human BioMolecular Research Institute, 6351 Nancy Ridge Drive, Suite B, San Diego, California 92121, United States.
Developing novel monoclonal antibodies (mAbs) with 2-PAM can enhance organophosphorus (OP) degradation. This approach may offer a new strategy to reduce OP toxicity by increasing clearance and promoting OP breakdown.
Area of Science:
- Biochemistry
- Toxicology
- Immunology
Background:
- Organophosphorus (OP) compounds pose a significant toxicological threat.
- Current treatments for OP exposure primarily manage symptoms and do not enhance OP clearance or degradation.
- Acetylcholinesterase (AChE) inhibition is the primary mechanism of acute OP toxicity.
Purpose of the Study:
- To develop novel therapeutic strategies for organophosphorus (OP) exposure.
- To create monoclonal antibodies (mAbs) capable of degrading OPs.
- To investigate the synergistic effect of mAbs and 2-PAM in OP detoxification.
Main Methods:
- Design of haptens using transition state analogy for antibody generation.
- Procurement and characterization of monoclonal antibodies (mAbs).
- Assessment of mAb efficacy in combination with 2-PAM for OP hydrolysis and degradation.
Main Results:
- Novel mAbs were generated that recognize and bind to OPs.
- The combination of mAbs and 2-PAM significantly increased the hydrolysis of paraoxon (POX).
- These mAbs promoted the degradation of nerve agent mimics in the presence of 2-PAM.
Conclusions:
- Monoclonal antibodies designed using transition state analogy show promise for OP degradation.
- The synergistic action of mAbs and 2-PAM offers a potential new therapeutic avenue for OP exposure.
- This approach could lead to improved methods for reducing OP toxicity by enhancing clearance and degradation.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Protecting Groups for Aldehydes and Ketones: Introduction
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
